Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110355918> ?p ?o ?g. }
- W2110355918 abstract "The evidence for choices between antipsychotics for children and adolescents with schizophrenia and other psychotic disorders is limited. The main objective of the Tolerability and Efficacy of Antipsychotics (TEA) trial is to compare the benefits and harms of quetiapine versus aripiprazole in children and adolescents with psychosis in order to inform rational, effective and safe treatment selections.The TEA trial is a Danish investigator-initiated, independently funded, multi-centre, randomised, blinded clinical trial. Based on sample size estimation, 112 patients aged 12-17 years with psychosis, antipsychotic-naïve or treated for a limited period are, 1:1 randomised to a 12- week, double-blind intervention with quetiapine versus aripiprazole. Effects on psychopathology, cognition, health-related quality of life, and adverse events are assessed 2, 4, and 12 weeks after randomisation. The primary outcome is change in the positive symptom score of the Positive and Negative Syndrome Scale. The recruitment period is 2010-2014.Antipsychotics are currently the only available pharmacologic treatments for psychotic disorders. However, information about head-to-head differences in efficacy and tolerability of antipsychotics are scarce in children and adolescents. The TEA trial aims at expanding the evidence base for the use of antipsychotics in early onset psychosis in order to inform more rational treatment decisions in this vulnerable population. Here, we account for the trial design, address methodological challenges, and discuss the estimation of sample size.ClinicalTrials.gov: NCT01119014." @default.
- W2110355918 created "2016-06-24" @default.
- W2110355918 creator A5000220990 @default.
- W2110355918 creator A5000655105 @default.
- W2110355918 creator A5001609083 @default.
- W2110355918 creator A5002953925 @default.
- W2110355918 creator A5003878022 @default.
- W2110355918 creator A5009344239 @default.
- W2110355918 creator A5011156420 @default.
- W2110355918 creator A5011239321 @default.
- W2110355918 creator A5013953628 @default.
- W2110355918 creator A5014755004 @default.
- W2110355918 creator A5016799676 @default.
- W2110355918 creator A5018342875 @default.
- W2110355918 creator A5019275846 @default.
- W2110355918 creator A5021023367 @default.
- W2110355918 creator A5023412928 @default.
- W2110355918 creator A5031129350 @default.
- W2110355918 creator A5032082404 @default.
- W2110355918 creator A5043047142 @default.
- W2110355918 creator A5051228367 @default.
- W2110355918 creator A5053654801 @default.
- W2110355918 creator A5054810759 @default.
- W2110355918 creator A5056944189 @default.
- W2110355918 creator A5064078426 @default.
- W2110355918 creator A5069281477 @default.
- W2110355918 creator A5070257445 @default.
- W2110355918 creator A5071978313 @default.
- W2110355918 creator A5078222323 @default.
- W2110355918 creator A5079090030 @default.
- W2110355918 creator A5088557617 @default.
- W2110355918 date "2014-07-11" @default.
- W2110355918 modified "2023-10-16" @default.
- W2110355918 title "Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial" @default.
- W2110355918 cites W145522907 @default.
- W2110355918 cites W1500540703 @default.
- W2110355918 cites W1592811749 @default.
- W2110355918 cites W1963733748 @default.
- W2110355918 cites W1964502734 @default.
- W2110355918 cites W1964957356 @default.
- W2110355918 cites W1974217915 @default.
- W2110355918 cites W1977028597 @default.
- W2110355918 cites W1983302342 @default.
- W2110355918 cites W1985132002 @default.
- W2110355918 cites W1987420874 @default.
- W2110355918 cites W1988024999 @default.
- W2110355918 cites W1990997731 @default.
- W2110355918 cites W1992179353 @default.
- W2110355918 cites W1993560189 @default.
- W2110355918 cites W1995516142 @default.
- W2110355918 cites W1996113429 @default.
- W2110355918 cites W1998151542 @default.
- W2110355918 cites W1999399995 @default.
- W2110355918 cites W1999689270 @default.
- W2110355918 cites W2000522086 @default.
- W2110355918 cites W2000636120 @default.
- W2110355918 cites W2005485433 @default.
- W2110355918 cites W2007345527 @default.
- W2110355918 cites W2008062633 @default.
- W2110355918 cites W2009052798 @default.
- W2110355918 cites W2009832071 @default.
- W2110355918 cites W2011675347 @default.
- W2110355918 cites W2012844013 @default.
- W2110355918 cites W2018365137 @default.
- W2110355918 cites W2021186654 @default.
- W2110355918 cites W2021833034 @default.
- W2110355918 cites W2022295086 @default.
- W2110355918 cites W2024417178 @default.
- W2110355918 cites W2024425840 @default.
- W2110355918 cites W2029926956 @default.
- W2110355918 cites W2030822991 @default.
- W2110355918 cites W2032586089 @default.
- W2110355918 cites W2036411341 @default.
- W2110355918 cites W2037401672 @default.
- W2110355918 cites W2040013231 @default.
- W2110355918 cites W2041948429 @default.
- W2110355918 cites W2042850223 @default.
- W2110355918 cites W2045218440 @default.
- W2110355918 cites W2047032381 @default.
- W2110355918 cites W2047316240 @default.
- W2110355918 cites W2048168735 @default.
- W2110355918 cites W2048731414 @default.
- W2110355918 cites W2049074524 @default.
- W2110355918 cites W2050493658 @default.
- W2110355918 cites W2053056955 @default.
- W2110355918 cites W2053914414 @default.
- W2110355918 cites W2057777484 @default.
- W2110355918 cites W2061393918 @default.
- W2110355918 cites W2068878814 @default.
- W2110355918 cites W2070017877 @default.
- W2110355918 cites W2073442736 @default.
- W2110355918 cites W2075039786 @default.
- W2110355918 cites W2078017090 @default.
- W2110355918 cites W2078396129 @default.
- W2110355918 cites W2078965693 @default.
- W2110355918 cites W2085184923 @default.
- W2110355918 cites W2089153987 @default.
- W2110355918 cites W2093318388 @default.
- W2110355918 cites W2096391232 @default.
- W2110355918 cites W2096730846 @default.